These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 10544178

  • 1. Fas (CD95, APO-1) antigen expression and function in murine liver endothelial cells: implications for the regulation of apoptosis in liver endothelial cells.
    Cardier JE, Schulte T, Kammer H, Kwak J, Cardier M.
    FASEB J; 1999 Nov; 13(14):1950-60. PubMed ID: 10544178
    [Abstract] [Full Text] [Related]

  • 2. Fas (CD95)- and tumor necrosis factor-mediated apoptosis in liver endothelial cells: role of caspase-3 and the p38 MAPK.
    Cardier JE, Erickson-Miller CL.
    Microvasc Res; 2002 Jan; 63(1):10-8. PubMed ID: 11749068
    [Abstract] [Full Text] [Related]

  • 3. Vascular endothelial cells and smooth muscle cells differ in expression of Fas and Fas ligand and in sensitivity to Fas ligand-induced cell death: implications for vascular disease and therapy.
    Sata M, Suhara T, Walsh K.
    Arterioscler Thromb Vasc Biol; 2000 Feb; 20(2):309-16. PubMed ID: 10669625
    [Abstract] [Full Text] [Related]

  • 4. Differential regulation of CD95 (Fas/APO-1) expression in human blood eosinophils.
    Luttmann W, Opfer A, Dauer E, Foerster M, Matthys H, Eibel H, Schulze-Osthoff K, Kroegel C, Virchow JC.
    Eur J Immunol; 1998 Jul; 28(7):2057-65. PubMed ID: 9692873
    [Abstract] [Full Text] [Related]

  • 5. Differential effect of IL-18 on endothelial cell apoptosis mediated by TNF-alpha and Fas (CD95).
    Mariño E, Cardier JE.
    Cytokine; 2003 Jun 07; 22(5):142-8. PubMed ID: 12842762
    [Abstract] [Full Text] [Related]

  • 6. On the role and significance of Fas (Apo-1/CD95) ligand (FasL) expression in immune privileged tissues and cancer cells using multiple myeloma as a model.
    Greil R, Egle A, Villunger A.
    Leuk Lymphoma; 1998 Nov 07; 31(5-6):477-90. PubMed ID: 9922038
    [Abstract] [Full Text] [Related]

  • 7. Proteasome inhibitors induce Fas-mediated apoptosis by c-Myc accumulation and subsequent induction of FasL message in human glioma cells.
    Tani E, Kitagawa H, Ikemoto H, Matsumoto T.
    FEBS Lett; 2001 Aug 24; 504(1-2):53-8. PubMed ID: 11522296
    [Abstract] [Full Text] [Related]

  • 8. Potentiation of Fas-mediated apoptosis of murine granulosa cells by interferon-gamma, tumor necrosis factor-alpha, and cycloheximide.
    Quirk SM, Porter DA, Huber SC, Cowan RG.
    Endocrinology; 1998 Dec 24; 139(12):4860-9. PubMed ID: 9832422
    [Abstract] [Full Text] [Related]

  • 9. Effects of interferon-gamma and tumour necrosis factor-alpha on CD95/Fas ligand-mediated apoptosis in human blood eosinophils.
    Luttmann W, Dauer E, Schmidt S, Marx O, Hossfeld M, Matthys H, Virchow JC.
    Scand J Immunol; 2000 Jan 24; 51(1):54-9. PubMed ID: 10632976
    [Abstract] [Full Text] [Related]

  • 10. Fas and Fas ligand in embryos and adult mice: ligand expression in several immune-privileged tissues and coexpression in adult tissues characterized by apoptotic cell turnover.
    French LE, Hahne M, Viard I, Radlgruber G, Zanone R, Becker K, Müller C, Tschopp J.
    J Cell Biol; 1996 Apr 24; 133(2):335-43. PubMed ID: 8609166
    [Abstract] [Full Text] [Related]

  • 11. Effect of IL-12 on TNF-alpha-mediated osteoclast formation in bone marrow cells: apoptosis mediated by Fas/Fas ligand interaction.
    Kitaura H, Nagata N, Fujimura Y, Hotokezaka H, Yoshida N, Nakayama K.
    J Immunol; 2002 Nov 01; 169(9):4732-8. PubMed ID: 12391181
    [Abstract] [Full Text] [Related]

  • 12. Fas receptor (CD95)-mediated apoptosis in leukemic cells.
    Komada Y, Sakurai M.
    Leuk Lymphoma; 1997 Mar 01; 25(1-2):9-21. PubMed ID: 9130610
    [Abstract] [Full Text] [Related]

  • 13. Fas induces apoptosis in human coronary artery endothelial cells in vitro.
    Filippatos G, Ang E, Gidea C, Dincer E, Wang R, Uhal BD.
    BMC Cell Biol; 2004 Jan 22; 5():6. PubMed ID: 14738570
    [Abstract] [Full Text] [Related]

  • 14. Local Fas/APO-1 (CD95) ligand-mediated tumor cell killing in vivo.
    Rensing-Ehl A, Frei K, Flury R, Matiba B, Mariani SM, Weller M, Aebischer P, Krammer PH, Fontana A.
    Eur J Immunol; 1995 Aug 22; 25(8):2253-8. PubMed ID: 7545115
    [Abstract] [Full Text] [Related]

  • 15. CD40 activation-induced, Fas-dependent apoptosis and NF-kappaB/AP-1 signaling in human intrahepatic biliary epithelial cells.
    Afford SC, Ahmed-Choudhury J, Randhawa S, Russell C, Youster J, Crosby HA, Eliopoulos A, Hubscher SG, Young LS, Adams DH.
    FASEB J; 2001 Nov 22; 15(13):2345-54. PubMed ID: 11689460
    [Abstract] [Full Text] [Related]

  • 16. Perforin-independent CD8(+) T-cell-mediated cytotoxicity of alveolar epithelial cells is preferentially mediated by tumor necrosis factor-alpha: relative insensitivity to Fas ligand.
    Liu AN, Mohammed AZ, Rice WR, Fiedeldey DT, Liebermann JS, Whitsett JA, Braciale TJ, Enelow RI.
    Am J Respir Cell Mol Biol; 1999 May 22; 20(5):849-58. PubMed ID: 10226053
    [Abstract] [Full Text] [Related]

  • 17. Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage.
    Galle PR, Hofmann WJ, Walczak H, Schaller H, Otto G, Stremmel W, Krammer PH, Runkel L.
    J Exp Med; 1995 Nov 01; 182(5):1223-30. PubMed ID: 7595193
    [Abstract] [Full Text] [Related]

  • 18. TNF-alpha and IFN-gamma render microglia sensitive to Fas ligand-induced apoptosis by induction of Fas expression and down-regulation of Bcl-2 and Bcl-xL.
    Spanaus KS, Schlapbach R, Fontana A.
    Eur J Immunol; 1998 Dec 01; 28(12):4398-408. PubMed ID: 9862377
    [Abstract] [Full Text] [Related]

  • 19. Fas ligand is present in human erythroid colony-forming cells and interacts with Fas induced by interferon gamma to produce erythroid cell apoptosis.
    Dai CH, Price JO, Brunner T, Krantz SB.
    Blood; 1998 Feb 15; 91(4):1235-42. PubMed ID: 9454753
    [Abstract] [Full Text] [Related]

  • 20. Regulation of cell surface expression of Fas (CD95) ligand and susceptibility to Fas (CD95)-mediated apoptosis in activation-induced T cell death involves calcineurin and protein kinase C, respectively.
    Tóth R, Szegezdi E, Molnár G, Lord JM, Fésüs L, Szondy Z.
    Eur J Immunol; 1999 Feb 15; 29(2):383-93. PubMed ID: 10064053
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.